Authors
Loading...
Angiogenesis inhibitors may heighten thrombotic risk via endothelial effects; leaves open whether targeted prophylaxis improves outcomes in trials.
Key points are not available for this paper at this time.
Bart C. Kuenen (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: